PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, United States of America.\', \'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, United States of America; Massachusetts Institute of Technology, Cambridge, MA 02139, United States of America.\', \'Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, United States of America.\', \'Brigham and Women\'s Hospital, Boston, MA 02115, United States of America.\', \'Division of Infectious Disease, Massachusetts General Hospital, Boston, MA 02114, United States of America.\', \'Massachusetts Institute of Technology, Cambridge, MA 02139, United States of America.\', \'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, United States of America; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, United States of America.\', \'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, United States of America. Electronic address: galter@partners.org.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0022-1759(20)30116-210.1016/j.jim.2020.112832
?:hasPublicationType
?:journal
  • Journal of immunological methods
is ?:pmid of
?:pmid
?:pmid
  • 32780998
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.289
?:rankingScore_hIndex
  • 119
?:title
  • SARS-CoV-2-specific ELISA development.
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32780998>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32780998>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all